##### Table of Contents



UNITED STATES SECURITIES AND
    EXCHANGE COMMISSIONWashington, D.C.
    20549
      Form 10-Q
      (Mark One)þ

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended September 30, 2006oro

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period
    from          
    to          .    Commission file number: 01-10920
      Fisher Scientific International
    Inc.
 (Exact name of registrant as
    specified in its charter)
  Delaware(State or other
    jurisdiction of
    incorporation or organization)

02-0451017(I.R.S. Employer
    Identification No.)Liberty Lane, Hampton New
    Hampshire(Address of principal
    executive offices)

03842(Zip Code)    Registrants telephone number, including area code:
 (603) 926-5911
   þ o
  Rule 12b-2
 þ o o
    rule 12b-2 o þ




---



##### 



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  FORM 10-Q
 For the Quarter Ended September 30, 2006
  INDEX
  
  Page No.Part I 

FINANCIAL
    INFORMATION:Item 1 

Financial
    Statements:Consolidated
    Statement of Operations  Three and Nine Months Ended
    September 30, 2006 and 2005 (unaudited)


2Consolidated
    Balance Sheet  September 30, 2006 (unaudited)
    and December 31, 2005


3Consolidated
    Statement of Cash Flows  Nine Months Ended
    September 30, 2006 and 2005 (unaudited)


4Consolidated
    Statement of Changes in Stockholders
    Equity  Nine Months Ended September 30,
    2006 (unaudited)


5Notes to
    Consolidated Financial Statements


6Item 2 

Managements
    Discussion and Analysis of Financial Condition and Results of
    Operations


23Item 3 

Quantitative and
    Qualitative Disclosures About Market Risk


30Item 4 

Controls and
    Procedures


31Part II 

OTHER
    INFORMATION:Item 4 

Submission of
    Matters to Security Holders


32Item 6 

Exhibits


32SIGNATURE


33EX-31.01 Section 302 CEO CertificationEX-31.02 SEC 302 CFO CertificationEX-32.01 Section 906 CEO CertificationEX-32.02 Section 906 CFO Certification   1




---



##### Table of Contents



PART I 
    FINANCIAL INFORMATION Item 1 
    Financial Statements  FISHER
    SCIENTIFIC INTERNATIONAL INC.
 CONSOLIDATED STATEMENT OF OPERATIONS

(In millions, except per share data)

(Unaudited) Three Months Ended


Nine Months EndedSeptember 30,


September 30,2006


2005


2006


2005Net sales

$
1,508.1


$
1,361.3


$
4,386.3


$
4,011.2Cost of sales


963.4



884.6



2,787.1



2,620.0Selling, general and
    administrative expenses


333.5



302.7



1,036.5



900.3Restructuring expense


1.2



4.3



5.3



17.5Operating income


210.0



169.7



557.4



473.4Interest expense


33.8



21.9



95.7



80.1Other (income) expense, net


(16.3
)


36.1



(22.8
)


63.9Income from continuing operations
    before income taxes


192.5



111.7



484.5



329.4Income tax provision


43.2



17.4



107.6



73.5Income from continuing operations


149.3



94.3



376.9



255.9Income (loss) from discontinued
    operations, including gain on disposal of $0.3 and $17.0 for the
    three and nine month periods ended September 30, 2005, net
    of tax


2.5



(0.8
)


0.1



16.0Net income

$
151.8


$
93.5


$
377.0


$
271.9Earnings per share:Basic net income per common share:Income from continuing operations

$
1.20


$
0.78


$
3.03


$
2.12Income (loss) from discontinued
    operations


0.02



(0.01
)


0.00



0.13Net income

$
1.22


$
0.77


$
3.03


$
2.25Diluted net income per common
    share:Income from continuing operations

$
1.12


$
0.74


$
2.86


$
2.01Income (loss) from discontinued
    operations


0.02



(0.01
)


0.00



0.13Net income

$
1.14


$
0.73


$
2.86


$
2.14Weighted average common shares
    outstanding:Basic


124.9



122.2



124.3



120.9Diluted


133.0



128.5



131.7



127.2    2




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
 CONSOLIDATED
    BALANCE SHEET

(In millions, except per share data) September 30,


December 31,2006


2005(Unaudited)ASSETSCurrent assets:Cash and cash equivalents

$
279.2


$
407.2Accounts receivable, net


805.3



679.4Inventories


646.1



589.0Other current assets


279.7



276.2Assets held for sale


41.3



39.5Total current assets


2,051.6



1,991.3Property, plant and equipment, net


843.3



788.2Goodwill


4,100.6



3,769.8Intangible assets, net


1,710.0



1,569.1Other assets


314.9



268.1Assets held for sale


53.5



59.2Total assets

$
9,073.9


$
8,445.7LIABILITIES AND
    STOCKHOLDERS
    EQUITYCurrent liabilities:Short-term debt

$
38.2


$
74.5Accounts payable


489.5



479.9Accrued and other current
    liabilities


452.0



429.5Liabilities held for sale


25.4



30.9Total current liabilities


1,005.1



1,014.8Long-term debt


2,111.9



2,135.4Other long-term liabilities


1,032.7



983.0Liabilities held for sale


8.1



8.2Total liabilities


4,157.8



4,141.4Commitments and contingenciesStockholders equity:Preferred stock ($0.01 par
    value; 15,000,000 shares authorized; none outstanding)






Common stock ($0.01 par
    value; 500,000,000 shares authorized; 125,257,129 and
    123,656,538 shares issued; 125,003,261 and
    123,401,563 shares outstanding at September 30, 2006
    and December 31, 2005, respectively)


1.2



1.2Capital in excess of par value


4,312.2



4,191.9Retained earnings


506.0



129.0Accumulated other comprehensive
    income (loss)


100.6



(13.8
)Treasury stock, at cost
    (253,868 shares at September 30, 2006 and
    254,975 shares at December 31, 2005)


(3.9
)


(4.0
)Total stockholders equity


4,916.1



4,304.3Total liabilities and
    stockholders equity

$
9,073.9


$
8,445.7    3




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
 CONSOLIDATED
    STATEMENT OF CASH FLOWS

(In millions)

(Unaudited) Nine Months EndedSeptember 30,2006


2005Cash flows from operating
    activities:Net income

$
377.0


$
271.9Adjustments to reconcile net
    income to net cash provided by operating activities:Depreciation


96.2



98.4Amortization of intangible assets


52.1



38.7Amortization, other


12.9



12.4Redemption premiums and deferred
    financing fees






69.4Stock-based compensation expense


38.9



Deferred income taxes


44.1



40.6Other non cash items


1.0



Gain on sale of business and
    investments


(12.4
)


(25.4
)Loss on sale of property and
    impairment of property, plant and equipment


3.5



9.8Changes in working capitalAccounts receivable, net


(87.8
)


(91.5
)Inventories


(32.8
)


3.0Other current assets


3.0



10.5Accounts payable


(1.5
)


10.7Accrued and other current
    liabilities


(32.8
)


(46.7
)Other assets and liabilities


(37.7
)


(6.0
)Cash provided by operating
    activities


423.7



395.8Cash flows from investing
    activities:Acquisitions, net of cash acquired


(470.2
)


(263.8
)Capital expenditures


(115.4
)


(100.3
)Proceeds from sale of a business


1.0



109.5Proceeds from sale of property,
    plant and equipment


0.2



9.0Other


(16.6
)


(1.0
)Cash used in investing activities


(601.0
)


(246.6
)Cash flows from financing
    activities:Proceeds from stock options
    exercised and stock purchase plan


61.9



119.0Tax benefit of stock options


27.9



Long term debt proceeds






497.3Debt payments


(60.9
)


(647.4
)Proceeds from revolving credit
    facility


1,041.5



56.6Revolving credit facility payments


(1,041.5
)


(56.6
)Debt redemption premium and other
    costs






(77.4
)Deferred financing costs






(0.9
)Cash provided by (used in)
    financing activities


28.9



(109.4
)Effect of exchange rate changes on
    cash and cash equivalents


20.4



(13.1
)Net change in cash and cash
    equivalents


(128.0
)


26.7Cash and cash
    equivalents  beginning of period


407.2



162.5Cash and cash
    equivalents  end of period

$
279.2


$
189.2    4




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
 CONSOLIDATED
    STATEMENT OF CHANGES IN STOCKHOLDERS EQUITY

(In millions, except share data)

(Unaudited) Shares to





AccumulatedCapital in


Shares


be





Other


Treasury Stock,Common Stock


Excess of


Deposited


Distributed


Retained


Comprehensive


at CostShares


Amount


Par Value


in Trust


from Trust


Earnings


Income (Loss)


Shares


Amount


TotalBalance at January 1, 2006


123,656,538


$
1.2


$
4,191.9


$
(16.9
)

$
16.9


$
129.0


$
(13.8
)


254,975


$
(4.0
)

$
4,304.3Net income






















377.0















377.0Foreign currency translation
    adjustment


























119.2











119.2Unrealized investment loss, net of
    tax


























(5.2
)










(5.2
)Unrealized gain on cash flow
    hedges, net of tax


























0.4











0.4Proceeds from stock options and
    other


1,599,484







61.9



























61.9Tax benefit from stock options










19.5



























19.5Stock-based compensation expense










38.9



























38.9Trust activity


1,107











1.5



(1.5
)










(1,107
)


0.1



0.1Balance at September 30, 2006


125,257,129


$
1.2


$
4,312.2


$
(15.4
)

$
15.4


$
506.0


$
100.6



253,868


$
(3.9
)

$
4,916.1    5




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL STATEMENTS
 (Unaudited)
  Note 1 
    Nature of Operations
    Scientific products and services segment and/or
  Healthcare products and services segment
  Form S-4,
     6




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
          Hart-Scott-Rodino
  Note 2 
    Basis of Presentation
  Form 8-K
     7




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    Note 3 
    Stock-Based Compensation
  Summary
    of stock-based compensation plans
        10-year and/or
 8




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  stock-for-stock
  Change
    in accounting for stock-based compensation plans
      Three Months


Nine MonthsEnded


EndedSeptember 30,


September 30,2006


2006Cost of sales

$
0.1


$
0.3Selling, general and administrative


12.7



38.6Stock-based compensation expense
    before tax


12.8



38.9Less: income tax benefit


(4.5
)


(13.8
)Net stock-based compensation
    expense

$
8.3


$
25.1     Three Months


Nine MonthsEnded


EndedSeptember 30,


September 30,2006


2006Income from continuing operations
    before income taxes

$
12.8


$
38.9Income from continuing operations

$
8.3


$
25.1Net income

$
8.3


$
25.1Cash flows from operating
    activities

$
8.3


$
25.1Cash flows from financing
    activities

$
3.9


$
27.9Basic earnings per share

$
0.07


$
0.20Diluted earnings per share

$
0.06


$
0.19  9




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    Three Months


Nine MonthsEnded


EndedSeptember 30,


September 30,2005


2005Net income, as reported

$
93.5


$
271.9Add: stock-based employee
    compensation included in net income, net of tax,(a)


0.3



2.0Deduct: stock-based compensation
    expense determined using fair value based method for all awards,
    net of tax


(9.4
)


(21.2
)Net income, pro forma

$
84.4


$
252.7Net income per common shareAs reported:Basic

$
0.77


$
2.25Diluted

$
0.73


$
2.14Pro forma:Basic

$
0.69


$
2.09Diluted

$
0.66


$
1.98     (a)
    
    Stock-based compensation expense for the three and nine month
    periods ended September 30, 2005 includes approximately
    $0.7 million of expense associated with the accelerated
    vesting of approximately 42,000 employee options in
    connection with the Companys sale of Atos Medical Holding
    AB.    2006


2005Expected stock price volatility


34
%


29
%Risk free interest rate


4.9
%


3.9
%Expected life of options


4.7 years



4.7 yearsExpected annual dividends






      10




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  Stock
    Options
    WeightedStock


AverageOptions


Exercise PriceOutstanding at January 1, 2006


11,469


$
43.01Granted


80



73.73Exercised


(1,592
)


38.52Canceled/expired/forfeited


(237
)


62.65Outstanding at September 30,
    2006


9,720


$
43.53Exercisable at September 30,
    2006


7,305


$
37.53     Options Outstanding


Options ExercisableWeighted Average


Weighted





Weighted


Weighted AverageNumber


Remaining


Average


Number


Average


RemainingOutstanding


Contractual Life


Exercise


Exercisable


Exercise


Exercisable LifeRange of Exercise Price

(in 000s)


(in Years)


Price


(in 000s)


Price


(in Years)$ 9.00 - $13.00


760



1.3


$
9.50



760


$
9.50



1.313.01 - 17.00


3



2.0



14.16



3



14.16



2.017.01 - 21.00


82



2.4



18.23



82



18.23



2.421.01 - 25.00


742



4.4



23.97



742



23.97



4.425.01 - 29.00


1,415



5.4



28.46



1,415



28.46



5.429.01 -  33.00


559



4.9



30.14



559



30.14



4.933.01 -  37.00


47



4.3



34.52



47



34.52



4.337.01 - 41.00


1,467



2.5



39.20



1,447



39.20



2.541.01 - 45.00


374



5.7



44.41



305



44.41



5.345.01 - 49.00


67



7.2



47.93



67



47.93



7.249.01 - 54.00


60



7.4



53.45



39



53.44



7.454.01 - 59.00


704



7.9



56.75



314



56.72



7.759.01 - 64.00


1,699



8.5



61.29



895



61.26



8.464.01 - 69.00


1,661



8.8



64.59



630



64.60



8.869.01 - 74.00


80



9.6



73.73











9,720











7,305      11




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    Restricted Stock


Weighted AverageUnits


Grant-DateNon-Vested Restricted Stock Units

(in 000s)


Fair ValueNon-vested at January 1, 2006


3.0


$
64.48Granted


1,030.6



66.07Forfeited


(28.1
)


65.68Non-vested at September 30,
    2006


1,005.5


$
66.08       Note 4 
    Discontinued Operations
      September 30,


December 31,2006


2005Accounts receivable, net

$
20.9


$
17.6Inventories


17.0



16.6Other current assets


3.4



5.3Total current assets


41.3



39.5Property, plant, and equipment


39.6



43.1Other assets


13.9



16.1Total assets

$
94.8


$
98.7Accounts payable


15.8



21.2Accrued and other current
    liabilities


9.6



9.7Total current liabilities


25.4



30.9Other liabilities


8.1



8.2Total liabilities

$
33.5


$
39.1  12




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    Three Months


Nine MonthsEnded


EndedSeptember 30,


September 30,2006


2005


2006


2005Net sales

$
45.9


$
51.7


$
129.9


$
144.3Income (loss) before income taxes


4.0



(0.6
)


0.2



(0.8
)(Provision) benefit for income
    taxes


(1.5
)


(0.5
)


(0.1
)


(0.4
)Income (loss) from discontinued
    operations, net of tax


2.5



(1.1
)


0.1



(1.2
)       Three Months Ended


Nine Months EndedSeptember 30, 2005


September 30, 2005Net sales

$



$
10.4Income before income taxes






0.4Provision for income taxes






0.2Income from discontinued
    operations, net of tax






0.2   Note 5 
    Business Combinations
       13




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  Note 6 
    Inventories
    September 30,


December 31,2006


2005Raw materials

$
162.6


$
138.1Work in process


70.2



71.7Finished products


413.3



379.2Total

$
646.1


$
589.0   Note 7 
    Goodwill and Other Intangible Assets
      September 30,


December 31,2006


2005Scientific products and services

$
2,846.9


$
2,708.3Healthcare products and services


1,253.7



1,061.5$
4,100.6


$
3,769.8     WeightedAverage


September 30, 2006


December 31, 2005Amortization


Net





NetPeriod


Carrying


Accumulated


Carrying


Accumulated(Years)


Amount


Amortization


Amount


AmortizationCustomer relationships


17.6


$
333.6


$
61.2


$
296.4


$
41.0Non-compete agreements


4.8



3.9



12.5



1.7



12.1Patents and tradenames


14.7



14.6



8.4



13.3



6.3Developed technology


8.6



263.5



65.1



181.3



39.8Supplier arrangements


9.2



15.2



6.7



16.5



4.8Other amortizable intangible assets


12.7



12.6



15.3



24.7



11.1Total other intangible assets
    subject to amortization


13.3


$
643.4


$
169.2


$
533.9


$
115.1Indefinite-lived intangible assets






1,066.6







1,035.2Total other intangible assets





$
1,710.0






$
1,569.1    14




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    For the Year Ended December 31,2006(a)

$
20.82007

$
61.42008

$
64.62009

$
60.62010

$
56.6Thereafter

$
379.4     (a)
    
    Amount represents estimated amortization expense for the
    remaining three months ended December 31, 2006.  Note 8 
    Debt
    September 30,


December 31,2006


2005Revolver

$



$
Term Facility


359.8



381.22.50% Convertible Senior
    Notes due 2023, convertible at $47.46 per share


300.0



300.0Floating Rate Convertible Senior
    Debentures due 2033, convertible at $59.09 per share


344.6



344.63.25% Convertible Senior
    Subordinated Notes due 2024, convertible at $80.40 per share


330.0



330.063/4% Senior
    Subordinated Notes due 2014


300.0



300.061/8% Senior
    Subordinated Notes due 2015 (includes $2.5 million and
    $2.6 million of unamortized debt discount at
    September 30, 2006 and December 31, 2005, respectively)


497.5



497.4Other debt


18.2



56.7Total debt


2,150.1



2,209.9Less: short-term portion


(38.2
)


(74.5
)Total long-term debt

$
2,111.9


$
2,135.4        15




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    Note 9 
    Equity
      Note 10 
    Employee Benefit Plans
      Three Months Ended September 30,OtherPension


SERP


PostretirementBenefits


Benefits


Benefits2006


2005


2006


2005


2006


2005Components of net periodic
    benefit cost (income)Service cost

$
2.8


$
5.2


$
0.7


$
0.6


$



$
0.3Interest cost


8.2



7.3



0.8



0.8



0.4



0.6Expected return on plan assets


(10.1
)


(9.6
)














Amortization of unrecognized net
    loss (gain)


0.9



(0.1
)


0.2



0.1



(0.5
)


Amortization of unrecognized prior
    service cost (benefit)


0.1



(0.2
)


0.5



0.4



(0.4
)


(0.4
)Recognized net actuarial loss
    (gain)


0.6



1.0











0.1



(0.4
)Settlement/curtailment loss


0.3



0.2







0.2







Net periodic benefit cost (income)

$
2.8


$
3.8


$
2.2


$
2.1


$
(0.4
)

$
0.1   16




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  Nine Months Ended September 30,OtherPension


SERP


PostretirementBenefits


Benefits


Benefits2006


2005


2006


2005


2006


2005Components of net periodic
    benefit cost (income)Service cost

$
11.7


$
15.8


$
2.1


$
1.9


$
0.2


$
0.4Interest cost


24.2



22.9



2.5



2.2



1.2



1.5Expected return on plan assets


(29.8
)


(29.1
)














Amortization of unrecognized net
    lost (gain)


2.6



(0.4
)


0.7



0.4







Amortization of unrecognized prior
    service cost (benefit)


0.1



(0.5
)


1.3



1.2



(1.4
)


(1.1
)Recognized net actuarial lost
    (gain)


1.7



3.0











(1.2
)


(1.3
)Settlement/curtailment (gain) loss


(0.3
)


1.6







0.3



0.1



Net periodic benefit cost (income)

$
10.2


$
13.3


$
6.6


$
6.0


$
(1.1
)

$
(0.5
)     Note 11 
    Earnings Per Share
      Three Months Ended


Nine Months EndedSeptember 30,


September 30,2006


2005


2006


2005Net income available to common
    shareholders

$
151.8


$
93.5


$
377.0


$
271.9Weighted average common shares
    outstanding used in computing basic net income per common share


124.9



122.2



124.3



120.9Dilutive securities:Stock options, restricted stock
    units and warrants(a)


4.4



4.3



4.3



4.6Convertible notes


3.7



2.0



3.1



1.7Weighted average common shares
    outstanding used in computing diluted net income per common share


133.0



128.5



131.7



127.2Basic net income per common share

$
1.22


$
0.77


$
3.03


$
2.25Diluted net income per common share

$
1.14


$
0.73


$
2.86


$
2.14  17




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    (a)
    
    The weighted average number of outstanding antidilutive common
    stock options and warrants excluded from the computation of
    diluted net income per common share for the three and nine month
    periods ended September 30, 2006 was 0.1 million and
    0.2 million, respectively, and for the three and nine month
    periods ended September 30, 2005 was 1.9 million and
    2.0 million, respectively.  No. 04-08 No. 90-19
    2.50%


Floating Rate


3.25%Convertible Senior


Convertible Senior


Convertible SeniorNotes


Debentures


Subordinated NotesIssuance amount (in millions)

$
300.0


$
344.6


$
330.0Conversion price per share

$
47.46


$
59.09


$
80.40Trigger price

$
56.96


$
76.82


$
96.48   Total Potential Shares2.50%


Floating Rate


3.25%


PotentialConvertible Senior


Convertible Senior


Convertible Senior


ShareFuture Fisher Common Stock Price

Notes


Debentures


Subordinated Notes


Increase$47.46














$48.46


0.1











0.1$59.09


1.2











1.2$60.09


1.3



0.1







1.4$80.40


2.6



1.5







4.1$81.40


2.6



1.6



0.1



4.3$90.00


3.0



2.0



0.4



5.4   Note 12 
    Restructuring Plan Activities
   18




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  lease-related
    December 31,


2006


2006


September 30,2005


Charges


Payments


20062006 Plans

$



$
4.2


$
(2.4
)

$
1.82004 Plan


5.3



1.1



(4.6
)


1.8Pre 2004 Plans


0.7







(0.3
)


0.4Total restructuring

$
6.0


$
5.3


$
(7.3
)

$
4.0     Note 13 
    Commitments and Contingencies
      Note 14 
    Segment Information
   19




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
    Three Months Ended


Nine Months EndedSeptember 30,


September 30,2006


2005


2006


2005Net Sales:Scientific products and services

$
1,165.3


$
1,060.1


$
3,368.2


$
3,074.3Healthcare products and services


362.1



317.5



1,072.0



980.4Eliminations


(19.3
)


(16.3
)


(53.9
)


(43.5
)Net Sales

$
1,508.1


$
1,361.3


$
4,386.3


$
4,011.2   Three Months Ended


Nine Months EndedSeptember 30,


September 30,2006


2005


2006


2005Operating income:Scientific products and services

$
173.8


$
144.9


$
476.4


$
416.5Healthcare products and services


53.1



41.7



152.6



126.3Eliminations










(0.1
)


(0.1
)Segment sub-total


226.9



186.6



628.9



542.7Other charges:Restructuring expense


(1.2
)


(4.3
)


(5.3
)


(17.5
)Acquisition, integration and other
    costs


(2.9
)


(12.0
)


(25.0
)


(31.1
)Equity-based compensation expense


(12.8
)






(38.9
)


Inventory
    step-up






(0.6
)


(2.3
)


(20.7
)Operating income

$
210.0


$
169.7


$
557.4


$
473.4   step-up
 20




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  Note 15 
    Income Tax
    Three Months Ended September 30,2006


%


2005


%Taxes computed at statutory rate

$
67.4



35.0
%

$
39.1



35.0
%Foreign tax rate differential and
    foreign losses not tax benefited


(18.5
)


(9.6
)%


(8.6
)


(7.7
)%State income taxes, net of federal
    benefit


(0.3
)


(0.2
)%


0.9



0.8
%Export sales benefit


(0.7
)


(0.4
)%


(2.0
)


(1.8
)%Nondeductible permanent items, net


0.9



0.5
%


(0.2
)


(0.2
)%Tax audits settled






0.0
%


(6.8
)


(6.1
)%Foreign tax credits benefited


(0.7
)


(0.4
)%


(0.8
)


(0.7
)%Valuation allowances


(4.3
)


(2.2
)%


(2.1
)


(1.9
)%Other


(0.6
)


(0.3
)%


(2.1
)


(1.8
)%Income tax provision

$
43.2



22.4
%

$
17.4



15.6
%   Nine Months Ended September 30,2006


%


2005


%Taxes computed at statutory rate

$
169.6



35.0
%

$
115.3



35.0
%Foreign tax rate differential and
    foreign losses not tax benefited


(44.2
)


(9.1
)%


(31.6
)


(9.6
)%State income taxes, net of federal
    benefit


5.6



1.2
%


4.8



1.5
%Export sales benefit


(2.1
)


(0.4
)%


(4.1
)


(1.2
)%Nondeductible permanent items, net


1.7



0.3
%


0.8



0.2
%Tax audits settled






0.0
%


(6.8
)


(2.1
)%Foreign tax credits benefited


(1.2
)


(0.3
)%


(0.8
)


(0.2
)%Valuation allowances


(17.6
)


(3.6
)%


(2.1
)


(0.6
)%Other


(4.2
)


(0.9
)%


(2.0
)


(0.7
)%Income tax provision

$
107.6



22.2
%

$
73.5



22.3
%  21




---



##### Table of Contents



FISHER
    SCIENTIFIC INTERNATIONAL INC.
  NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
  Note 16 
    Recent Accounting Pronouncements
       22




---



##### Table of Contents



Item 2 
    Managements Discussion and Analysis of Financial
    Condition and Results of Operations  Form 10-Q Form 10-Q Form 8-K
  Results
    of Operations
  Form S-4,
  Hart-Scott-Rodino
  Executive
    Overview
      Sales
    Three Months Ended September 30,2006


2005Net


Sales


Net


SalesSales


Growth


Sales


GrowthScientific products and services

$
1,165.3



9.9
%

$
1,060.1



12.1
%Healthcare products and services


362.1



14.0
%


317.5



15.5
%Eliminations


(19.3
)






(16.3
)Total

$
1,508.1



10.8
%

$
1,361.3



12.4
%  23




---



##### Table of Contents



Nine Months Ended September 30,2006


2005Net


Sales


Net


SalesSales


Growth


Sales


GrowthScientific products and services

$
3,368.2



9.6
%

$
3,074.3



24.0
%Healthcare products and services


1,072.0



9.3
%


980.4



35.8
%Eliminations


(53.9
)






(43.5
)Total

$
4,386.3



9.4
%

$
4,011.2



25.9
%   Consolidated.
  Scientific Products and Services.
  Healthcare Products and Services.
 24




---



##### Table of Contents



Operating
    Income
    Three Months Ended September 30,Operating Income as a Percentage ofOperating Income


Net Sales2006


2005


2006


2005Scientific products and services

$
173.8


$
144.9



14.9%



13.7%Healthcare products and services


53.1



41.7



14.7%



13.1%Eliminations






Sub-total


226.9



186.6



15.0%



13.7%Other charges:Restructuring expense


(1.2
)


(4.3
)






Inventory
    step-up






(0.6
)






Equity based compensation expense


(12.8
)










Acquisition, integration and other
    costs


(2.9
)


(12.0
)






Operating income

$
210.0


$
169.7



13.9%



12.5%   Nine Months Ended September 30,Operating Income as a Percentage ofOperating Income


Net Sales2006


2005


2006


2005Scientific products and services

$
476.4


$
416.5



14.1%



13.5%Healthcare products and services


152.6



126.3



14.2%



12.9%Eliminations


(0.1
)


(0.1
)Segment sub-total


628.9



542.7



14.3%



13.5%Other charges:Restructuring expense


(5.3
)


(17.5
)






Inventory
    step-up


(2.3
)


(20.7
)






Equity-based compensation expense


(38.9
)










Acquisition, integration and other
    costs


(25.0
)


(31.1
)






Operating income

$
557.4


$
473.4



12.7%



11.8%   Consolidated. step-up
 25




---



##### Table of Contents



step-up
  Scientific Products and Services.
  Healthcare Products and Services.
  Change in
    accounting for stock-based compensation plans
  ,
    Restructuring
    Plan Activities
   26




---



##### Table of Contents



December 31,


2006


2006


September 30,2005


Charges


Payments


20062006 Plans

$



$
4.2


$
(2.4
)

$
1.82004 Plan


5.3



1.1



(4.6
)


1.8Pre 2004 Plans


0.7







(0.3
)


0.4Total restructuring

$
6.0


$
5.3


$
(7.3
)

$
4.0     Discontinued
    Operations
      Interest
    Expense
  1 8 1 8
  Other
    (Income) Expense, net
  1 8
  Income
    Tax Provision
   27




---



##### Table of Contents



Liquidity
    and Capital Resources
      1 8 1 8
      Form 8-K
   28




---



##### Table of Contents



Hart-Scott-Rodino
  Form S-4
  Critical
    Accounting Policies/Estimates
  Form 8-K
 29




---



##### Table of Contents



Recent
    Accounting Pronouncements
       Item 3 
    Quantitative and Qualitative Disclosures About Market
    Risk  Financial
    Instruments
      non-U.S. activities,
  Interest
    Rate Risk and Management
   30




---



##### Table of Contents



Currency
    Risk Management
        Commodity
    Risk Management
      Item 4 
    Controls and Procedures  Form 10-Q, Rule 13a-15(e)
 31




---



##### Table of Contents



PART II 
    OTHER INFORMATION Item 4 
    Submission of Matters to Security Holders     Item 6 
    Exhibits  Exhibit 31
.01:

Certification pursuant to
    Section 302 of the Sarbanes-Oxley Act of 2002Exhibit 31
.02:

Certification pursuant to
    Section 302 of the Sarbanes-Oxley Act of 2002Exhibit 32
.01:

Certification pursuant to
    18 U.S.C. Section 1350, as adopted pursuant to
    Section 906 of the Sarbanes-Oxley Act of 2002Exhibit 32
.02:

Certification pursuant to
    18 U.S.C. Section 1350, as adopted pursuant to
    Section 906 of the Sarbanes-Oxley Act of 2002  32




---



##### Table of Contents



SIGNATURE    Fisher Scientific
    International Inc.
  Kevin
    P. Clark
    Vice President and Chief Financial Officer
  (Principal Financial and Accounting Officer)
   33